NCT01009697已完成1 期
A Single Dose, 3-Period, 3-Treatment, 6-Sequence, 3-Way Crossover Study of the Dose Linearity of Codeine Sulfate Tablets Under Fasting Conditions
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 34
- 试验地点
- 1
- 主要终点
- bioequivalence determined by statistical comparison Cmax
研究概览
简要总结
The objective of this study was to examine the dose linearity of Roxane Laboratories' 15 mg, 30 mg, and 60 mg codeine sulfate tablets under fasted conditions
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening.
排除标准
- •Positive test for HIV, Hepatitis B, or Hepatitis C.
- •Treatment with known enzyme altering drugs.
- •History of allergic or adverse response to Codeine Sulfate or any comparable or similar product.
结局指标
主要结局
bioequivalence determined by statistical comparison Cmax
时间窗: 21 Days
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Pharmacokinetic and Comparative Bioavailability Study of Codeine Sulfate Under Fasted ConditionsPainNCT01010139Roxane Laboratories18
已完成
1 期
A Study to Evaluate the Pharmacokinetics of Abiraterone in Healthy Chinese Male ParticipantsHealthyNCT01678573Janssen Research & Development, LLC15
已完成
1 期
A Pharmacokinetic Study to Assess the Influence of P-glycoprotein Inhibition and Simultaneous CYP3A4 and P-glycoprotein Induction on E7080 Pharmacokinetics Following Single Dose Oral Administration of 24 mg E7080 to Healthy VolunteersP-glycoproteinHealthy VolunteersNCT02199392Eisai Inc.15
撤回
1 期
Dose Response and Efficacy of GW842166 in PainHealthy SubjectsNCT00554762GlaxoSmithKline
已完成
3 期
A Study of Monthly Risedronate for OsteoporosisPostmenopausal OsteoporosisNCT00247273Warner Chilcott1,294